TABLE OF CONTENTS
Volume 25, Issue 35 (10 August 2006)
Original Articles
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer FREE
T Furukawa, N Kanai, H O Shiwaku, N Soga, A Uehara and A Horii
Oncogene 25: 4831-4839; advance online publication, March 13, 2006; doi:10.1038/sj.onc.1209494
Functional analyses of the TEL-ARNT fusion protein underscores a role for oxygen tension in hematopoietic cellular differentiation FREE
F Nguyen-Khac, V Della Valle, R G Lopez, E Ravet, M Mauchauffé, A D Friedman, L E Huang, S Fichelson, J Ghysdael and O A Bernard
Oncogene 25: 4840-4847; advance online publication, March 20, 2006; doi:10.1038/sj.onc.1209503
B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis FREE
K Boisvert-Adamo and A E Aplin
Oncogene 25: 4848-4856; advance online publication, March 20, 2006; doi:10.1038/sj.onc.1209493
Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways
T-H Wang, Y-H Chan, C-W Chen, W-H Kung, Y-S Lee, S-T Wang, T-C Chang and H-S Wang
Oncogene 25: 4857-4866; advance online publication, March 20, 2006; doi:10.1038/sj.onc.1209498
Subcellular localization and nucleocytoplasmic transport of the chromosomal passenger proteins before nuclear envelope breakdown
J A Rodriguez, S M A Lens, S W Span, G Vader, R H Medema, F A E Kruyt and G Giaccone
Oncogene 25: 4867-4879; advance online publication, March 20, 2006; doi:10.1038/sj.onc.1209499
E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells
K Piltti, L Kerosuo, J Hakanen, M Eriksson, A Angers-Loustau, S Leppä, M Salminen, H Sariola and K Wartiovaara
Oncogene 25: 4880-4889; advance online publication, March 13, 2006; doi:10.1038/sj.onc.1209492
Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation
P Lund, K Wei
haupt, T Mikeska, D Jammas, X Chen, R-J Kuban, U Ungethüm, U Krapfenbauer, H-P Herzel, R Schäfer, J Walter and C Sers
Oncogene 25: 4890-4903; advance online publication, March 27, 2006; doi:10.1038/sj.onc.1209502
Identification of STAT3 as a specific substrate of breast tumor kinase
L Liu, Y Gao, H Qiu, W T Miller, V Poli and N C Reich
Oncogene 25: 4904-4912; advance online publication, March 27, 2006; doi:10.1038/sj.onc.1209501
Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
D Hägerstrand, G Hesselager, S Achterberg, U Wickenberg Bolin, M Kowanetz, M Kastemar, C-H Heldin, A Isaksson, M Nistér and A Östman
Oncogene 25: 4913-4922; advance online publication, March 20, 2006; doi:10.1038/sj.onc.1209497
Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells
J Shi, A Kahle, J W B Hershey, B M Honchak, J A Warneke, S P L Leong and M A Nelson
Oncogene 25: 4923-4936; advance online publication, March 13, 2006; doi:10.1038/sj.onc.1209495
p78/MCRS1 forms a complex with centrosomal protein Nde1 and is essential for cell viability
Y Hirohashi, Q Wang, Q Liu, X Du, H Zhang, N Sato and M I Greene
Oncogene 25: 4937-4946; advance online publication, March 20, 2006; doi:10.1038/sj.onc.1209500
Oncogenomics
Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology
P Ruminy, F Jardin, J M Picquenot, P Gaulard, F Parmentier, G Buchonnet, C Maisonneuve, H Tilly and C Bastard
Oncogene 25: 4947-4954; advance online publication, April 17, 2006; doi:10.1038/sj.onc.1209512
